Skip to main content

Articles

Page 45 of 60

  1. An impaired endothelial function has been recognized in the early stage of atherosclerosis, and is a major factor affecting the future development of cardiovascular events. Type 2 diabetes mellitus (T2DM) is w...

    Authors: Jun-ichi Oyama, Yukihito Higashi and Koichi Node
    Citation: Cardiovascular Diabetology 2014 13:21
  2. To investigate whether flow-mediated dilation (FMD) impairment, which precedes overt atherosclerosis, is associated with silent myocardial ischemia (SMI) and asymptomatic coronary artery disease (CAD) in type ...

    Authors: Minh Tuan Nguyen, Isabelle Pham, Paul Valensi, Hélène Rousseau, Eric Vicaut, Christelle Laguillier-Morizot, Alain Nitenberg and Emmanuel Cosson
    Citation: Cardiovascular Diabetology 2014 13:20
  3. Patients with diabetes mellitus are at increased risk for microvascular complications. Early changes in microcirculation are characterized by hyperperfusion (e.g. in the retina and kidney) and increased pulse ...

    Authors: Christian Ott, Ulrike Raff, Stephanie Schmidt, Iris Kistner, Stefanie Friedrich, Peter Bramlage, Joanna M Harazny and Roland E Schmieder
    Citation: Cardiovascular Diabetology 2014 13:19
  4. High density lipoproteins (HDL) have many cardioprotective roles; however, in subjects with type 2 diabetes (T2D) these cardioprotective properties are diminished. Conversely, increased fruit and vegetable (F&...

    Authors: Jane-Ann Daniels, Ciara Mulligan, David McCance, Jayne V Woodside, Christopher Patterson, Ian S Young and Jane McEneny
    Citation: Cardiovascular Diabetology 2014 13:16
  5. The purpose of this study was to elucidate the effects of glimepiride on the levels of biomarkers related to cardiovascular regulation in patients with type 2 diabetes mellitus.

    Authors: Ikuko Nakamura, Jun-ichi Oyama, Hiroshi Komoda, Aya Shiraki, Yoshiko Sakamoto, Isao Taguchi, Atsushi Hiwatashi, Aiko Komatsu, Masayoshi Takeuchi, Sho-ichi Yamagishi, Teruo Inoue and Koichi Node
    Citation: Cardiovascular Diabetology 2014 13:15
  6. C1q/TNF-related protein-3 (CTRP-3), an adiponectin paralog, and progranulin were recently identified as novel adipokines which may link obesity with glucose dysregulation and subclinical inflammation. We analy...

    Authors: Kyung Mook Choi, Soon Young Hwang, Ho Chel Hong, Hae Yoon Choi, Hye Jin Yoo, Byung-Soo Youn, Sei Hyun Baik and Hong Seog Seo
    Citation: Cardiovascular Diabetology 2014 13:14
  7. Diabetes mellitus (DM) accelerates plaque progression despite the use of statin therapy. The purpose of the present study was to evaluate the determinants of atheroma progression in statin-treated patients wit...

    Authors: Tsuyoshi Nozue, Shingo Yamamoto, Shinichi Tohyama, Kazuki Fukui, Shigeo Umezawa, Yuko Onishi, Tomoyuki Kunishima, Akira Sato, Toshihiro Nozato, Shogo Miyake, Youichi Takeyama, Yoshihiro Morino, Takao Yamauchi, Toshiya Muramatsu, Kiyoshi Hibi, Mitsuyasu Terashima…
    Citation: Cardiovascular Diabetology 2014 13:13
  8. Coronary heart disease and type-2 diabetes are both major global health burdens associated with an increased risk of myocardial infarction (MI). Following MI, ischaemia-reperfusion injury (IRI) remains a signi...

    Authors: Sophie J Clarke, Liam M McCormick and David P Dutka
    Citation: Cardiovascular Diabetology 2014 13:12
  9. Cardiomyopathy and distal symmetrical polyneuropathy (DSPN), including sensory and autonomic dysfunction, often co-occur in diabetic mellitus (DM) patients. However, the temporal relationship and progression b...

    Authors: Maria N Marangoni, Scott T Brady, Shamim A Chowdhury and Mariann R Piano
    Citation: Cardiovascular Diabetology 2014 13:11
  10. The adipocyte-derived hormone leptin plays a key role in the regulation of appetite and body weight. Recent studies have suggested that leptin is also involved in the pathogenesis of obesity-related atheroscle...

    Authors: Tomoaki Morioka, Masanori Emoto, Yuko Yamazaki, Naoya Kawano, Satoshi Imamura, Ryutaro Numaguchi, Hiromi Urata, Koka Motoyama, Katsuhito Mori, Shinya Fukumoto, Hidenori Koyama, Tetsuo Shoji and Masaaki Inaba
    Citation: Cardiovascular Diabetology 2014 13:10
  11. The complement system is part of the immune system in acute coronary syndrome (ACS). Adiponectin has anti-atherogenic and anti-inflammatory properties. Adiponectin and C1q form a protein complex in blood, and ...

    Authors: Ken Kishida, Yasuhiko Nakagawa, Hironori Kobayashi, Toru Mazaki, Hiroyoshi Yokoi, Koji Yanagi, Tohru Funahashi and Iichiro Shimomura
    Citation: Cardiovascular Diabetology 2014 13:9
  12. High blood and tissue concentrations of glucose and advanced glycation end-products are believed to play an important role in the development of vascular complications in patients with diabetes mellitus (DM) a...

    Authors: Tali Zitman-Gal, Janice Green, Metsada Pasmanik-Chor, Eliezer Golan, Jacques Bernheim and Sydney Benchetrit
    Citation: Cardiovascular Diabetology 2014 13:8
  13. With increasing numbers of type 2 diabetes (DM2) and hypertension patients, there is a pressing need for effective, time-efficient and sustainable strategies to help physicians support their patients to achiev...

    Authors: Kaberi Dasgupta, Ellen Rosenberg and Stella S Daskalopoulou
    Citation: Cardiovascular Diabetology 2014 13:7
  14. Type 2 diabetes mellitus (T2DM) is often associated with atherosclerotic changes in coronary vessels, most notably plaques. The angiostatic parameter endostatin is able to inhibit angiogenesis in tissue as wel...

    Authors: Michael Sponder, Daniela Dangl, Stephanie Kampf, Monika Fritzer-Szekeres and Jeanette Strametz-Juranek
    Citation: Cardiovascular Diabetology 2014 13:6
  15. The Fas apoptotic pathway has been implicated in type 2 diabetes and cardiovascular disease. Although a polymorphism (rs7138803; G > A) near the Fas apoptotic inhibitory molecule 2 (FAIM2) locus has been related ...

    Authors: Dolores Corella, Jose V Sorlí, José I González, Carolina Ortega, Montserrat Fitó, Monica Bulló, Miguel Angel Martínez-González, Emilio Ros, Fernando Arós, José Lapetra, Enrique Gómez-Gracia, Lluís Serra-Majem, Valentina Ruiz-Gutierrez, Miquel Fiol, Oscar Coltell, Ernest Vinyoles…
    Citation: Cardiovascular Diabetology 2014 13:5
  16. Diabetes is known to alter the energy metabolism of the heart. Thus, it may be expected to affect the efficiency of contraction (i.e., the ratio of mechanical work output to metabolic energy input). The litera...

    Authors: June-Chiew Han, Soyeon Goo, Carolyn J Barrett, Kimberley M Mellor, Andrew J Taberner and Denis S Loiselle
    Citation: Cardiovascular Diabetology 2014 13:4
  17. Diabetes is associated with a high risk of death due to coronary artery disease (CAD). People with diabetes suffering from CAD are frequently treated with revascularization procedures. We aim to compare trends...

    Authors: Ana Lopez-de-Andres, Rodrigo Jimenez-García, Valentin Hernandez-Barrera, Napoleon Perez-Farinos, Jose M de Miguel-Yanes, Manuel Mendez-Bailon, Isabel Jimenez-Trujillo, Angel Gil de Miguel, Carmen Gallardo Pino and Pilar Carrasco-Garrido
    Citation: Cardiovascular Diabetology 2014 13:3
  18. Obesity is associated with increased risk for stroke. The breath-holding index (BHI) is a measure of vasomotor reactivity of the brain which can be measured with the transcranial Doppler (TCD). We aim to evalu...

    Authors: Marcela Rodríguez-Flores, Eduardo García-García, Claudia Vanessa Cano-Nigenda and Carlos Cantú-Brito
    Citation: Cardiovascular Diabetology 2014 13:2
  19. The role played by T helper cytokines under chronic, low grade inflammation as seen in type-2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD) co-morbidity is less well studied. In the present study,...

    Authors: Haridoss Madhumitha, Viswanathan Mohan, Mohan Deepa, Subash Babu and Vivekanandhan Aravindhan
    Citation: Cardiovascular Diabetology 2014 13:1
  20. An increased leukocyte count is an independent risk factor for cardiovascular events, but the association between leukocyte subtype counts and carotid atherosclerosis in patients with diabetes has not been det...

    Authors: Takeshi Matsumura, Kayo Taketa, Hiroyuki Motoshima, Takafumi Senokuchi, Norio Ishii, Hiroyuki Kinoshita, Kazuki Fukuda, Sarie Yamada, Daisuke Kukidome, Tatsuya Kondo, Aya Hisada, Takahiko Katoh, Seiya Shimoda, Takeshi Nishikawa and Eiichi Araki
    Citation: Cardiovascular Diabetology 2013 12:177
  21. The lipocalin-2 (LCN2) cytokine, primarily known as a protein of the granules of human neutrophils, has been recently reported to be implicated in metabolic and inflammatory disorders. This study was designed ...

    Authors: Jie Ni, Xiaojing Ma, Mi Zhou, Xiaoping Pan, Junling Tang, Yaping Hao, Zhigang Lu, Meifang Gao, Yuqian Bao and Weiping Jia
    Citation: Cardiovascular Diabetology 2013 12:176
  22. The anti-diabetic drug metformin has been demonstrated to exert a protective effect against vascular complications in diabetes independent of its glucose lowering action. Since the endothelial glycocalyx has b...

    Authors: Bart JM Eskens, Coert J Zuurbier, Judith van Haare, Hans Vink and Jurgen WGE van Teeffelen
    Citation: Cardiovascular Diabetology 2013 12:175
  23. Previous studies suggested an impaired endothelial function in patients with diabetes. However, the validity of this finding may be limited by the lack of adequate adjustment for further cardiovascular confoun...

    Authors: Klaus Empen, Roberto Lorbeer, Henry Völzke, Thorsten Reffelmann, Sabine Schipf, Matthias Nauck, Wolfgang Kerner, Henri Wallaschofski, Stephan B Felix and Marcus Dörr
    Citation: Cardiovascular Diabetology 2013 12:174
  24. Atherosclerosis is a major health burden. Metabolic disorders had been associated with large consumption of soft drinks. The rising incidence of atherosclerosis and metabolic alterations warrants the study of ...

    Authors: Matilde E Otero-Losada, Santiago Mc Loughlin, Gastón Rodríguez-Granillo, Angélica Müller, Graciela Ottaviano, Marisa Moriondo, Juan C Cutrin and José Milei
    Citation: Cardiovascular Diabetology 2013 12:57
  25. We have searched if plasma high density lipoprotein-cholesterol (HDL-C) concentration interferes simultaneously with whole-body cholesterol metabolism and insulin sensitivity in normal weight healthy adult sub...

    Authors: Camila C Leança, Valéria S Nunes, Natália B Panzoldo, Vanessa S Zago, Eliane S Parra, Patrícia M Cazita, Matti Jauhiainen, Marisa Passarelli, Edna R Nakandakare, Eliana C de Faria and Eder CR Quintão
    Citation: Cardiovascular Diabetology 2013 12:173
  26. Cardiac steatosis and apoptosis are key processes in diabetic cardiomyopathy, but the underlying mechanisms have not been elucidated, leading to a lack of effective therapy. The mineralocorticoid receptor bloc...

    Authors: Elisa Ramírez, Mercedes Klett-Mingo, Sara Ares-Carrasco, Belén Picatoste, Alessia Ferrarini, Francisco J Rupérez, Alicia Caro-Vadillo, Coral Barbas, Jesús Egido, José Tuñón and Óscar Lorenzo
    Citation: Cardiovascular Diabetology 2013 12:172
  27. The presence of diabetes and plasma glucose concentration on admission are associated with adverse outcomes after an acute myocardial infarction (AMI), as high glucose can induce vascular endothelial cell apop...

    Authors: Jing Chang, Gong Zhang, Li Zhang, Yuan-Ping Hou, Xiu-Lan Liu and Lin Zhang
    Citation: Cardiovascular Diabetology 2013 12:171
  28. Ethnic-specific differences in insulin resistance (IR) are well described but the underlying mechanisms are unknown. Adiponectin is an insulin sensitizing adipocytokine that circulates as multiple isoforms, wi...

    Authors: Dian C Sulistyoningrum, Danijela Gasevic, Scott A Lear, Joe Ho, Andrew Mente and Angela M Devlin
    Citation: Cardiovascular Diabetology 2013 12:170
  29. Diabetes-induced organ damage is significantly associated with the activation of the renin-angiotensin system (RAS). Recently, several studies have demonstrated a change in the RAS from an extracellular to an ...

    Authors: Qian Chen Yong, Candice M Thomas, Rachid Seqqat, Niketa Chandel, Kenneth M Baker and Rajesh Kumar
    Citation: Cardiovascular Diabetology 2013 12:169
  30. Elevated plasma preprovasopressin (copeptin) levels are associated with cardiovascular complications as well as with an increased risk for type 2 diabetes (T2D). Here, we studied, whether plasma copeptin is re...

    Authors: Cornelia Then, Bernd Kowall, Andreas Lechner, Christa Meisinger, Margit Heier, Wolfgang Koenig, Annette Peters, Joachim Thiery, Wolfgang Rathmann and Jochen Seissler
    Citation: Cardiovascular Diabetology 2013 12:168
  31. Long pentraxin 3 (PTX3) is a component of the pentraxin superfamily and a potential marker of vascular damage and inflammation, associated with negative outcome in patients with acute coronary syndromes (ACS)....

    Authors: Rocco Barazzoni, Aneta Aleksova, Cosimo Carriere, Maria Rosa Cattin, Michela Zanetti, Pierandrea Vinci, Davide Stolfo, Gianfranco Guarnieri and Gianfranco Sinagra
    Citation: Cardiovascular Diabetology 2013 12:167
  32. Bilirubin has been implicated in cardiovascular protection by virtue of its anti-inflammatory and anti-oxidative properties. The metabolic syndrome is featured by enhanced low-grade systemic inflammation and o...

    Authors: Petronella E Deetman, Stephan JL Bakker and Robin PF Dullaart
    Citation: Cardiovascular Diabetology 2013 12:166
  33. We investigated whether serum glycated albumin (GA) levels are related to coronary collateralization in type 2 diabetic patients with chronic total occlusion.

    Authors: Ying Shen, Lin Lu, Feng Hua Ding, Zhen Sun, Rui Yan Zhang, Qi Zhang, Zheng Kun Yang, Jian Hu, Qiu Jing Chen and Wei Feng Shen
    Citation: Cardiovascular Diabetology 2013 12:165
  34. There is little information about predictive ability of haemoglobin A1c (HbA1c) for cardiovascular disease (CVD) in Asians. To investigate the discriminatory ability of HbA1c to identify subjects who are at gr...

    Authors: Fumie Ikeda, Yasufumi Doi, Toshiharu Ninomiya, Yoichiro Hirakawa, Naoko Mukai, Jun Hata, Kentaro Shikata, Daigo Yoshida, Takayuki Matsumoto, Takanari Kitazono and Yutaka Kiyohara
    Citation: Cardiovascular Diabetology 2013 12:164
  35. There are numerous reports describing the efficacy of fenofibrate in combination with ezetimibe for treating dyslipidemia. In contrast, a study combining bezafibrate and ezetimibe has not yet been conducted. I...

    Authors: Tamio Teramoto, Kazunori Abe and Takehiko Taneyama
    Citation: Cardiovascular Diabetology 2013 12:163
  36. We tested whether fatty liver, brachial-ankle pulse wave velocity (baPWV) and conventional cardiovascular risk factors were associated with a coronary artery calcium (CAC) score > 0 (as a marker of the presenc...

    Authors: Ki-Chul Sung, Young-Hyo Lim, Sungha Park, Seok-Min Kang, Jeong Bae Park, Byung-Jin Kim and Jin-Ho Shin
    Citation: Cardiovascular Diabetology 2013 12:162
  37. Coronary artery calcification (CAC) is closely related to coronary atherosclerosis. However, less is known about the clinical significance of extensive CAC (ECAC) in regard to types of first coronary events (a...

    Authors: Joseph Shemesh, Alexander Tenenbaum, Enrique Z Fisman, Nira Koren-Morag and Ehud Grossman
    Citation: Cardiovascular Diabetology 2013 12:161
  38. Dipeptidyl peptidase-4 (DPP-4) inhibitors modulate incretin hormones and exert anti-diabetic effects in type 2 diabetes mellitus. Treatment with angiotensin II type 1 receptor blockers (ARB) is a proven succes...

    Authors: Katsutoshi Miyagawa, Tatsuya Kondo, Rieko Goto, Rina Matsuyama, Kaoru Ono, Sayaka Kitano, Shuji Kawasaki, Motoyuki Igata, Junji Kawashima, Takeshi Matsumura, Hiroyuki Motoshima and Eiichi Araki
    Citation: Cardiovascular Diabetology 2013 12:160
  39. Angiotensin II type 1 receptor blockers (ARB) are a frequently used class of antihypertensive drug. The ARB losartan is known to decrease the serum uric acid (SUA) level. However, there are very few clinical d...

    Authors: Yayoi Nishida, Yasuo Takahashi, Norio Susa, Nobukazu Kanou, Tomohiro Nakayama and Satoshi Asai
    Citation: Cardiovascular Diabetology 2013 12:159
  40. Endoplasmic reticulum (ER) stress is considered one of the mechanisms contributing to reactive oxygen species (ROS)- mediated cell apoptosis. In diabetic cardiomyopathy (DCM), cell apoptosis is generally accep...

    Authors: Zhong-Wei Liu, Hai-Tao Zhu, Kun-Lun Chen, Xin Dong, Jin Wei, Chuan Qiu and Jia-Hong Xue
    Citation: Cardiovascular Diabetology 2013 12:158
  41. Cystatin C (Cys C) is a marker of renal dysfunction. Prior studies have shown that blood Cys C is related to the prognosis of coronary heart disease. The aim of the present study was to evaluate the long-term ...

    Authors: Zhenhong Fu, Hao Xue, Jun Guo, Lian Chen, Wei Dong, Luyue Gai, Hongbin Liu, Zhijun Sun and Yundai Chen
    Citation: Cardiovascular Diabetology 2013 12:157
  42. The presence of cardiovascular disease (CVD) in Type 1 diabetes largely impairs life expectancy. Hyperglycemia leading to an increase in oxidative stress is considered to be the key pathophysiological factor o...

    Authors: Oliver Schnell, Francesco Cappuccio, Stefano Genovese, Eberhard Standl, Paul Valensi and Antonio Ceriello
    Citation: Cardiovascular Diabetology 2013 12:156
  43. Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a predictor of cardiovascular events.

    Authors: Salvatore Novo, Angelica Peritore, Rosaria Linda Trovato, Francesco Paolo Guarneri, Daniela Di Lisi, Ida Muratori and Giuseppina Novo
    Citation: Cardiovascular Diabetology 2013 12:155
  44. The dipeptidyl peptidase-4 (DPP-4) inhibitors Sitagliptin and Vildagliptin lower blood glucose by augmenting endogenous levels of glucagon-like peptide-1 (GLP-1), an incretin which also confers cardioprotectio...

    Authors: Derek J Hausenloy, Hannah J Whittington, Abigail M Wynne, Shah S Begum, Louise Theodorou, Niels Riksen, Mihaela M Mocanu and Derek M Yellon
    Citation: Cardiovascular Diabetology 2013 12:154
  45. Detection of early vascular changes prior to clinical manifestations of atherosclerosis, such as increased arterial carotid intima-media thickness (CIMT) and impaired endothelial function is of paramount impor...

    Authors: Sema Ciftci Dogansen, Aysen Helvaci, Mine Adas and Suzan Deniz Onal
    Citation: Cardiovascular Diabetology 2013 12:153
  46. The combination of systemic arterial hypertension and diabetes mellitus (DM) induces greater cardiac remodeling than either condition alone. However, this association has been poorly addressed in senescent rat...

    Authors: Camila Moreno Rosa, Natasha Priscilla Xavier, Dijon Henrique Campos, Ana Angélica Henrique Fernandes, Marcelo Diarcadia Mariano Cezar, Paula Felippe Martinez, Antonio Carlos Cicogna, Camila Gimenes, Rodrigo Gimenes, Marina Politi Okoshi and Katashi Okoshi
    Citation: Cardiovascular Diabetology 2013 12:152
  47. Activation of the renin-angiotensin system (RAS) plays a critical role in the pathophysiology of myocardial infarction (MI) and the development of heart failure. Both angiotensin-converting enzyme 2 (ACE2) and...

    Authors: Wei Liu, Xinmin Zhou, Fenglei Yu, Jianguo Hu and Wen Hu
    Citation: Cardiovascular Diabetology 2013 12:151
  48. Activin A released from epicardial adipose tissue has been linked to contractile dysfunction and insulin resistance in cardiomyocytes. This study investigated the role of activin A in clinical diabetic cardiom...

    Authors: Weena JY Chen, Sabrina Greulich, Rutger W van der Meer, Luuk J Rijzewijk, Hildo J Lamb, Albert de Roos, Johannes WA Smit, Johannes A Romijn, Johannes B Ruige, Adriaan A Lammertsma, Mark Lubberink, Michaela Diamant and D Margriet Ouwens
    Citation: Cardiovascular Diabetology 2013 12:150
  49. Advanced glycation endproducts (AGEs) may play a role in the development of coronary artery calcification (CAC) in type 1 diabetes (T1DM). We studied plasma AGEs in association with T1DM and CAC, and whether o...

    Authors: Marcelle GA van Eupen, Miranda T Schram, Helen M Colhoun, Jean LJM Scheijen, Coen DA Stehouwer and Casper G Schalkwijk
    Citation: Cardiovascular Diabetology 2013 12:149

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions